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Abstract
Background: Health-related quality of life is increasingly recognised as an important outcome
measure that complements existing measures of clinical effectiveness. The education available on
this subject for different healthcare professionals is varied. This article describes the design,
implementation and evaluation of a Special Study Module on Health-Related Quality of Life for
undergraduate medical students at the University of Birmingham.
Methods: The course involves 10 hours of "guided discovery learning" covering core concepts of
Health-Related Quality of Life assessment including methodological considerations, use in clinical
trials, routine practice and in health policy followed by self-directed learning. The taught
components aim to provide students with the skills and knowledge to enable them to explore and
evaluate the use of quality of life assessments in a particular patient group, or setting, through self-
directed learning supported by tutorials.
Results: The use of case studies, recent publications and research, and discussion with a research
oncology nurse in task-based learning appeared to provide students with a stimulating environment
in which to develop their ideas and was reflected in the diverse range of subjects chosen by
students for self-directed study and the positive feedback on the module. Course evaluation and
student assessment suggests that quality of life education appears to integrate well within the
medical curriculum and allows students to develop and utilise skills of time-management and
independent, self-directed learning that can be applied in any context.
Conclusion: We suggest that education and training initiatives in quality of life may improve the
quality of studies, and help bridge the gap between research and clinical practice. Resources for
curriculum development on health-related quality of life have been developed by the International
Society for Quality of Life Research and may prove a useful tool to educators interested in this area.
Background
Health-related quality of life (HRQoL) is increasingly rec-
ognised as an important measure of clinical effectiveness,
used to provide evidence for licensing and policy deci-
sion-making[1,2]. Yet surveys of clinical investigators
have identified a range of problems with the way HRQoL
assessment is undertaken or information used, including:
lack of understanding of the justification and rationale for
HRQoL assessment, lack of guidance on implementing
assessments, and limited knowledge of the HRQoL litera-
ture[3,4]. These problems highlight the need for continu-
ing medical education on this subject, yet particularly
within the undergraduate medical curriculum, educa-
tional opportunities are somewhat limited.
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standing of methodological considerations for HRQoL
assessment and how to critically appraise and interpret
results. Despite detailed guidance on methodological con-
siderations for implementation and reporting of HRQoL
the comparison of treatment effects on HRQoL between
two groups is often complicated by missing data and the
quality of reporting of many clinical trials assessing
HRQoL inadequate[5,6]. This lack of information ham-
pers the appraisal of such trials and brings into question
the validity and generalizability of the results.
Courses organised by the European Organization for the
Research and Treatment of Cancer and the Eastern Coop-
erative Oncology Group in response to such findings, and
conferences such as those organised by the International
Society for Quality of Life Research (ISOQOL), aim to
improve the quality of studies and to bridge the gap
between HRQoL research and clinical practice[5,7-9].
Such educational initiatives are however primarily aimed
at postgraduates, clinical investigators or researchers.
Opportunities for undergraduate students to study this
subject in depth appear to be more restricted. For exam-
ple, at the University of Birmingham the concept of
HRQoL is touched on briefly in sessions on chronic illness
and palliative care, and students are encouraged to discuss
the ethical implications of quality adjusted life years in
NHS resource allocation, but have limited formal oppor-
tunity to develop a deeper understanding. Special study
modules (SSMs) provide an ideal opportunity for under-
graduates to study this developing area. Here we report
the design and implementation of a HRQoL SSM at the
University of Birmingham.
Methods
Development of a quality of life SSM
SSMs were introduced into the undergraduate medical
curriculum in response to recommendations, made by the
General Medical Council in Tomorrow's doctors[10,11],
to promote the development of lifelong learning skills
and provide an opportunity to explore topics outside the
core curriculum. At Birmingham the first in a series of
SSMs that form part of the Academic Skills Programme is
spread over 8 weeks in the second semester of Year 2 and
is a 10 credit module.[12] The 'Quality of Life' course was
offered for the first time in the 2003/4 academic year
alongside a diverse range of biological and non-biological
science subjects including: Cancer of the Gastro Intestinal
Tract, Psychotropic Drugs, Drama and Medicine, History
of Medicine, and Psychiatry, Law and Ethics. SSMs aim to
provide students with an opportunity to study a subject
that interests them in greater depth and in doing so to
develop and utilise skills of time-management and inde-
pendent, self-directed learning that can be applied in any
context. In addition the HRQoL module aimed to provide
students with the skills and knowledge to enable them to
explore and evaluate the use of HRQoL assessments in a
particular patient group, or setting, and to integrate their
findings with other aspects of the medical curriculum
including medical ethics and communication skills.
Course overview
The module consisted of six taught sessions (10 hours in
total duration) (Table 1), to provide students with an
overview of key areas, followed by self-directed study on
the use of HRQoL assessments in area of interest to the
student such as: patients with a particular disease, or in a
specific group (such as children, or the elderly) supported
Table 1: Overview of the Quality of Life Special Study module sessions and associated learning outcomes
Session Key Learning outcomes
1. What is QoL and why might we wish to assess it? • Provide definitions of the terms quality of life and health-related quality 
of life.
• Identify situations when the assessment of QoL may be appropriate 
and provide the rationale for such an assessment.
2. How can we measure QoL? • Identify the key features of generic and disease specific instruments and 
the advantages/disadvantages of such measures.
3. Methodological considerations for the assessment of QoL in a clinical 
trial.
• Discuss how to choose an appropriate instrument(s) to assess the 
QoL of patients with a particular disease.
• Describe methodological issues that should be considered when 
assessing QoL in a clinical trial.
4. Assessing the reporting of QoL in clinical trials • Be able to evaluate the reporting of QoL in clinical trials.
5. Use and assessment of QoL in routine clinical practice • Explain the potential advantages and disadvantages of routine QoL 
assessment.
6. How is QoL used in licensing/policy making? • Identify key issues that need to be addressed for QoL to be considered 
as a credible criterion in the drug regulatory process.
• Understand the different methods that are used for eliciting patient 
preferences.
• Define and perform simple calculations of quality adjusted life years 
and understand their use in cost-utility analysis.Page 2 of 5
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by two members of academic staff. The framework
adopted for the taught sessions can be described as
"guided discovery learning"[13]. All students were pro-
vided with a course handbook that described: the course
aims, assessment criteria, evaluation sheets, and a sum-
mary for each session containing a brief introduction to
the area for study, a series of tasks and a list of key refer-
ences.
Each session was structured so that learning outcomes and
key concepts were introduced through didactic teaching at
the start of the session. These ideas were then reinforced
and developed through task-based learning[14]. Exam-
ples of tasks that students were asked to undertake to pro-
mote self-directed learning included:
• Define HRQoL and using recently published clinical
studies identify situations when HRQoL assessment may
be appropriate.
• Perform an online search for HRQoL instruments and
identify their key properties.
• Plan how HRQoL would be assessed in a clinical trial
(based on a case study)
• Evaluate and discuss the reporting of HRQoL in two
published studies.
• Find out about clinical assessment of HRQoL (question
and answer session with a research oncology nurse).
• Review a presentation and summarise key points on the
use of HRQoL in licensing.
• Discuss the use of HRQoL in policy making (based on
case studies published by the National Institute for Clini-
cal Excellence).
• Complete a diary that considers how each session relates
to the subject chosen for independent study.
Students were encouraged to reflect and conceptualise
their findings through facilitated group discussion and to
complete a diary considering how each session related to
their chosen area for self-directed study. Students were
assessed on their contribution to the learning of the
group, their understanding and independence in relation
to their own study, and on their ability to communicate
effectively through a written report and audiovisual pres-
entation.
Results
The SSM has run with six students each year. Running the
course with such a small group of highly motivated stu-
dents appears to work well. The course evaluation sheets
and informal discussion with the students were positive
(Table 2) and revealed that they felt that the course com-
plemented other aspects of the curriculum, including con-
cepts covered in their ethics and behavioural science
courses such as euthanasia, health care rationing and
patient-centred consultation. Students particularly liked
the handbooks and task-based learning but felt that sup-
porting material such as original research papers could be
provided in a virtual learning environment which we will
Table 2: Examples of student feedback
Were you provided with clearly stated aims and objectives 
which were met during the course?
All students stated yes
Did you feel comfortable in contributing to group discussions, 
if not why not?
All students stated yes, with additional comments stating that "the 
atmosphere was conducive to contribution" and "made us feel 
comfortable and at ease"
Were there any particular strengths or weaknesses in the 
tutor's approach?
Strengths
"Appeared very organised and willing to provide individual time to 
students"
"Organised presentations and handouts.....very helpful"
"Encouraged everyone to participate. Having workbook to read before 
session was useful"
"V. approachable. Gave individual attention for essay planning. Good use 
of email".
"Clear instructions. Ensured everyone understood".
"Discussion with research nurse was excellent"
Weaknesses 
"Sometimes too much paper about trials but it was useful".
Do you have any suggestions for improvements either in the 
content or presentation of these sessions or any other 
comments?
"Put papers on WebCT" (virtual learning environment)
"No, I was very impressed!"
"Wide variety of info. Good timetable."
"Very well organised and enjoyable. Session with oncology nurse 
particularly useful as related our knowledge to clinical practice"
"Less papers given out".Page 3 of 5
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publications and research, and discussion with a research
oncology nurse in task-based learning appeared to pro-
vide students with a stimulating environment in which to
develop their ideas and was reflected in the diverse range
of subjects chosen by students for further study. Topics
chosen for independent study have included: assessment
of HRQoL in people with diseases such as AIDs, arthritis,
or post-stroke, or in particular patient groups such as chil-
dren, or the elderly. Other students have considered
diverse topics such as the ethics of HRQoL and euthana-
sia, whether HRQoL assessments have a place in routine
clinical care, and their role in health policy.
Discussion
Formative and summative assessment suggests that qual-
ity of life education appears to integrate well within the
medical curriculum since some students not only consid-
ered the subject in depth but also considered the ethical
implications of HRQoL assessment, resource allocation
implications, and the potential application of such assess-
ments in facilitating communication and in the promo-
tion of patient centred consultation[15]. It appears
therefore to represent an appropriate area for an SSM. It is
a fast-developing area of study, though one which is not
yet sufficiently central to daily practice to form part of a
core curriculum. More interestingly, it offers students an
opportunity to work in an area which focuses at one and
the same time on key clinical areas, and the evidence
which can guide practice: the ethical context of health
care: and the relationship between how one makes and
how one presents decisions as a health professional. It is
therefore very well placed to fulfil the aim of SSMs, to
offer learning of generic value.
Whilst SSMs appear to provide an ideal opportunity to
introduce undergraduates to the latest research on this
subject there is a need for continuing medical education
in this area. In recognition of this need the International
Society for Quality of Life Research (ISOQOL) has sug-
gested potential topics for inclusion in a HRQoL curricu-
lum and is working to develop a pool of educational
materials that could be used when developing courses or
workshops on this subject, for undergraduates, postgrad-
uates, clinicians and researchers[9]. Details of topics rec-
ommended for consideration when planning an
educational program can be found online and should
provide educators with a valuable resource[9]. All topics
identified by ISOQOL were covered to varying degrees in
the SSM; the contents of which are available to educators
upon request. During the taught components it was not
feasible to cover in detail quality of life issues in specific
populations; however, many students chose to develop
their knowledge of this in self-directed learning. The stu-
dent presentations allowed students to benefit from the
research undertaken by their peers.
Conclusion
Evaluation of HRQoL can provide patients, clinicians and
policy makers with valuable evidence on the effect of a
disease and its treatment on patients' well being and func-
tioning. We suggest that education and training initiatives
may improve the quality of studies, and help bridge the
gap between research and clinical practice.
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